Medtronic expands Acute Care & Monitoring portfolio in Europe with distribution agreement for Corsano wearable

By Published On: May 29, 2025Last Updated: June 10, 2025
Medtronic expands Acute Care & Monitoring portfolio in Europe with distribution agreement for Corsano wearable

Medtronic has announced a new strategic partnership with Corsano Health B.V., a MedTech company specialising in advanced real-time remote patient monitoring solutions.

Medtronic will exclusively distribute Corsano Health’s cutting-edge solution in Western Europe for hospital and hospital-at-home use, enhancing remote monitoring capabilities and transforming patient care across healthcare settings.

Additional terms of the agreement were not disclosed.

The multi-parameter wearable solution by Corsano Health is a state-of-the-art, medically-certified multi-sensor wearable designed for continuous monitoring of vital signs.

With features like heart rate, breathing rate, SpO2, cuffless non-invasive blood pressure monitoring, and ECG, the Corsano solution provides clinicians with seamless, real-time data to non-invasively monitor patients anytime, anywhere.

Marc De Martini is vice president, Western Europe Commercial, Acute Care and Monitoring business, which is part of the Medical Surgical Portfolio at Medtronic.

He said: “The Corsano multi-parameter wearable will enhance our portfolio of patient monitoring solutions and help to protect more patients in more places.

“Together, we are transforming the healthcare landscape, turning aspirations into reality, and forging a future where safety and excellence go hand in hand.”

Corsano Health’s CEO, Peter Stas, added: “Our mission at Corsano Health is to transform healthcare by delivering actionable insights that enhance patient outcomes—seamlessly, from hospital to home.

“Through this innovation, we aim to empower clinicians with advanced remote monitoring capabilities to simplify workflows and provide proactive care.

“Together, we are redefining connected care models to support the evolving needs of healthcare systems, addressing workforce shortages while enabling personalised and efficient patient management at every stage of care.”

This partnership underscores the critical role of continuous monitoring in optimising patient pathways.

The Corsano solution’s ability to provide unrestricted access to raw data for AI development further supports the commitment from Medtronic to integrating cutting-edge technology with world-class medical devices.

Ochre Bio appoints ex- Eli Lilly and AstraZeneca VP as Non-Executive Director
Brain training game offers new hope for drug-free pain management